Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Biomedicines|February 25, 2023
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer CellsAlessia Garufi, Riccardo Pettinari, Fabio Marchetti, et al.
Cancers|March 11, 2023
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic DiseasesAlessia Garufi, Valerio D'Orazi, Giuseppa Pistritto, et al.
Discover Oncology|April 23, 2025
Mechanistic insights and therapeutic strategies for targeting autophagy in pancreatic ductal adenocarcinomaFederica Michetti, Mara Cirone, Raffaele Strippoli, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2017
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditionsAlessia Garufi, Giuseppa Pistritto, Silvia Baldari, et al.
Biochimica Et Biophysica Acta|April 2, 2015
PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy inductionRoberta Gonnella, Marisa Granato, Antonella Farina, et al.
Oncotarget|September 5, 2015
Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppressionMarisa Granato, Maria Saveria Gilardini Montani, Mariarosari Filardi, et al.
Immunology Letters|September 8, 2007
Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activityMara Cirone, Giuseppe Lucania, Paola Bergamo, et al.
Oncology Reports|March 1, 2013
Cyclooxygenase-2 is induced by p38 MAPK and promotes cell survivalRosanna Parente, Elisabetta Trifirò, Francesca Cuozzo, et al.
Viruses|September 28, 2024
EZH2 Inhibition by DS3201 Triggers the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle and Potentiates the Effects Induced by SAHA in Primary Effusion Lymphoma CellsRoberta Gonnella, Flavia Collura, Vincenzo Corrado, et al.
Oncoimmunology|November 15, 2013
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cellsMara Cirone, Alessia Garufi, Livia Di Renzo, et al.
Pageof 13